Find out more about who we are, what we do and the people behind Epitopea.
Find out what makes us unique and the work we do with our revolutionary CryptoMapTM platform.
All the latest company news, press releases and updates from Epitopea.
Contact

News & Events

Revealing the true targets for next generation immunotherapies.
Learn More

Epitopea Strengthens Scientific Advisory Board with Appointment of Leading Authority in Cancer, Lisa Butterfield

Date: April 13, 2026 |
CAMBRIDGE, UK and MONTREAL, CANADA, 13 April 2026 — Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies […]
Read More

Epitopea Strengthens Scientific Advisory Board with Appointment of Four World Renowned Experts in Cancer Immunology and Immunotherapy

Date: September 18, 2025 |
CAMBRIDGE, UK and MONTREAL, CANADA, 18 September 2025 – Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, […]
Read More

Epitopea Expands its Clinical Development and Research Capabilities as it Accelerates to the Clinic

Date: July 10, 2025 |
CAMBRIDGE, UK and MONTREAL, CANADA, 10 July 2025 – Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, […]
Read More

Epitopea Announces Nature Cancer Paper on Novel Immunotherapy Targets in Melanoma and NSCLC

Date: May 27, 2025 |
Further Validates CryptigensTM as Actionable Targets for Cancer Immunotherapy Montreal, Quebec, & Cambridge, UK, 27 May 2025 – Epitopea, a […]
Read More

Epitopea Featured in BiotechTV

Date: May 9, 2025 |
Cambridge, UK based Epitopia is helping Merck (MSD) discover tumor associated antigens from the non-coding regions of the genome using […]
Read More

Epitopea Featured in Fierce Biotech

Date: February 19, 2025 |
Merck pens $300M-per-product collab with Epitopea to locate 'hidden' tumor antigens Merck & Co. has penned a $300 million biobucks-per-product […]
Read More
1 2 3

Upcoming Events

Connect with Epitopea at these upcoming events

Revealing Novel Targets For Next Generation Immunotherapies
© 2022 – 2026 Epitopea Ltd | All Rights Reserved
Created by FDM Digital